|
BCRX BioCryst Pharmaceuticals Inc 882796 |
| Balance Sheet |
|
Current Assets
|
$484,683,000.00 |
|
Assets
|
$557,851,000.00 |
|
Current Liabilities
|
$208,846,000.00 |
|
Liabilities
|
$1,012,140,000.00 |
|
Equity
|
$-454,289,000.00 |
|
Shares Out
|
255265000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$42,551,000.00 |
|
Investing Cash Flow
|
$-378,796,000.00 |
| Market Analysis |
Market Cap
|
$2,465,859,900.00 |
|
Price
|
$9.66 |
|
PB
|
2.34 |
|
EPS
|
0.31 |
|
PS
|
2.82 |
|
FCF
|
$41,939,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:20 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
1.12 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-2.98 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-04 |
0.15 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
0.16 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BCRX documents filed with the SEC.
BCRX Filings
Clear
